Table 3. Diagnostic Evaluation of Patients with and without Schizophrenia.
Test | No Schizophrenia N (%) |
Schizophrenia N (%) |
Test Use among Patients with Schizophrenia | |
---|---|---|---|---|
Unadjusted2 OR1 (95% CI) |
Adjusted3 OR (95% CI) |
|||
All Stages: | ||||
Bronchoscopy | 47,895 (50.2) | 631 (48.4) | 0.93 (0.84-1.04) | 0.88 (0.79-0.98) |
Fine Needle Aspiration | 39,677 (41.6) | 542 (41.6) | 1.00 (0.90-1.12) | 1.01 (0.90-1.13) |
Positron Emission Test | 11,428 (12.0) | 111 (8.5) | 0.68 (0.56-0.83) | 0.68 (0.56-0.83) |
Chest Computed Tomography | 80,640 (84.5) | 1,069 (82.0) | 0.84 (0.73-0.96) | 0.84 (0.73-0.98) |
Mediastinoscopy | 7,658 (8.0) | 77 (5.9) | 0.72 (0.57-0.91) | 0.75 (0.59-0.95) |
Stage II-IV: | ||||
Brain Magnetic Resonance Imaging | 144 (0.2) | ≤11 (0.2) | 1.08 (0.27-4.36) | 1.00 (0.25-4.06) |
If no PET: | ||||
Abdominal Computed Tomography | 32,054 (38.2) | 373 (31.3) | 0.74 (0.65-0.83) | 0.78 (0.69-0.88) |
Bone Scan (stages III-IV) | 28,625 (49.1) | 316 (41.2) | 0.73 (0.63-0.84) | 0.74 (0.64-0.86) |
OR = odds ratio
Logistic regression model, unadjusted
Logistic regression model, adjusted for age, gender, marital status, race/ethnicity, income, histology, comorbidities, and stage